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 2 
Summary  
In many insect species odorant-binding proteins (OBPs) are thought to be responsible 
for the transport of pheromones and other semiochemicals across the sensillum lymph 
to the olfactory receptors (ORs) within the antennal sensilla. In the silkworm Bombyx 
mori the OBPs are subdivided into three main subfamlies, pheromone-binding 
proteins (PBPs), general odorant-binding proteins (GOBPs) and antennal binding 
proteins (ABPs). We used the ‘MotifSearch’ algorithm to search for genes encoding 
putative OBPs in B. mori and found 13, many fewer than are found in the genomes of 
fruitflies and mosquitoes. The 13 genes include seven new ABP-like OBPs as well as 
the previously identified PBPs (three), GOBPs (two) and ABPx. Quantitative 
examination of transcript levels showed that BmorPBP1, BmorGOBP1, BmorGOBP2 
and BmorABPx are expressed at very high levels in the antennae and so could be 
involved in olfaction. A new two-phase binding assay, along with other established 
assays, showed that BmorPBP1, BmorPBP2, BmorGOBP2 and BmorABPx all bind 
to the B. mori sex pheromone component (10E,12Z)-hexadecadien-1-ol (bombykol). 
BmorPBP1, BmorPBP2 and BmorABPx also bind the pheromone component 
(10E,12Z)-hexadecadienal (bombykal) equally well, whereas BmorGOBP2 can 
discriminate between bombykol and bombykal.  X-ray structures show that when 
bombykol is bound to BmorGOBP2 it adopts a different conformation from that 
found when it binds to BmorPBP1. Binding to BmorGOBP2 involves hydrogen 
bonding to Arg110 rather than to the Ser56 as found for BmorPBP1. 
 
 
Keywords: olfaction, odorant-binding protein, semiochemicals, crystal structure, 
silkworm. 
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Introduction 
In insects odorant-binding proteins (OBPs) provide the initial molecular interactions 
for chemical signals (semiochemicals) such as pheromones and host odours and are thought to 
ferry the semiochemical molecules across the antennal sensillum lymph to the olfactory 
receptors (ORs). The involvement of pheromone-binding proteins (PBPs) and general 
odorant-binding proteins (GOBPs) in recognising and transporting pheromones and host 
odours is supported by the findings that they are highly concentrated (up to 10 mM) in the 
lymph of chemosensilla, that some are expressed specifically in antennae and that the 
distribution of the different subfamilies of OBPs is related to specific functional 
chemosensilla. 
1,2,3,4,5,6,7,8
  
All insect OBPs have six highly conserved cysteine residues 
9,10
 which form 
disulphide bridges stabilising the 3D structure. 
11,12,13
 This sequence motif has been used for 
genome-wide identification and annotation of OBP genes in a range of insect species. 
14,15,16,17
 
Based on their sequence and their expression patterns in male and female antennae, OBPs in 
lepidopteran species are usually divided into different subfamilies; the PBP 
18 
, the GOBP 
9,18,19
 and the antennal binding protein X homologues (ABPx). 
20
 PBPs of Lepidoptera are 
either specific to, or highly enriched in, the antennae of male moths and have been shown to 
bind the sex pheromones produced by females. 
2,21,22
 However, PBPs have also been found in 
the antennae of females and in male sensilla which are not pheromone-sensitive. 
20,23,24,25,26
 
GOBPs are usually expressed equally in the antennae of both sexes consistent with a 
proposed role in the detection of host volatiles. 
3,20,25,27,28,29,30
 ABPxs display limited sequence 
homology to PBPs and GOBPs but have the same sequence motif of the conserved cysteine 
residues as PBPs and GOBPs.
 20
 No specific role has yet been proposed for them.   
Although it has been shown in vitro that OBPs can facilitate the passage of 
semiochemicals to the ORs, where the response of the insect to the chemical signal is initiated 
31,32,33,34,35,36
, there is no conclusive evidence showing this in vivo. Thus the exact functional 
roles that these proteins play in insect olfaction remain unclear. In at least one case, the 
 4 
ligand-OBP complex may activate the OR directly rather than by releasing the odorant 
molecule to the OR. 
37
  
In the silkworm Bombyx mori, four putative PBPs and five GOBPs have been 
observed by iso-electric focussing and mobility in native gel electrophoresis and N-terminal 
microsequencing. 
27,38
 The PBP, BmorPBP1, was first isolated from male antennae 
39
 and the 
corresponding gene was cloned, together with genes for BmorGOBP1, BmorGOBP2 and 
BmorABPx, by screening a male antennal cDNA library.
 20
 BmorGOBP2 was found to be 
expressed at a very high level in the long sensilla of female moths. 
21
 BmorPBP1 and its 
binding to pheromone components have been the subject of intense study in recent years as a 
model system for understanding the functions that OBPs may play in insect olfaction. 
40,41,42,43,44,45,46
 Cells expressing BmorPBP1 are closely associated with the cells expressing 
BmorOR-1 and BmorOR-3 in the long sensilla. 
8,47
 Co-expression of BmorPBP1 with 
BmorOR-1 in an ‘empty’ neuron of Drosophila melanogaster 48 increased sensitivity of the 
receptor to the sex pheromone component (10E,12Z)-hexadecadien-1-ol (bombykol). 
33
 
BmorPBP1 has also been shown to mediate a response to bombykol but not to another 
pheromone component (10E,12Z)-hexadecadienal (bombykal) in cultured HEK 295 cells 
expressing BmorOR-1. 
34 
The authors also proposed that there was another unidentified PBP 
responsible for mediating the bombykal response observed in the long sensillum.
 34
 They have 
recently identified two additional PBP genes encoding BmorPBP2 and BmorPBP3 but neither 
protein is co-expressed with BmorPBP1 and BmorOR-1 in the long sensilla. 
49
  
Pheromones are usually blends of chemicals specific to a species and for B. mori the 
pheromone blend comprises bombykol, bombykal and (10E,12E)-hexadecadien-1-ol. 
50
 
However, only bombykol is able to induce mating behaviour at a physiological concentration 
and bombykal acts as an antagonist to bombykol.
50,51
 Binding of BmorPBP1 to bombykol has 
been demonstrated by X-ray crystallography,
13 
 NMR structural characterisation, 
43,44,46
  
electrospray-mass spectrometry (ESI-MS) 
52,53
 and other biochemical methods. 
40,42
 It has 
been shown that the binding is both pH and ligand dependent. 
43,44
 At acidic pH, or in the 
 5 
absence of bombykol, the C-terminus forms an α-helix and occupies the ligand binding 
pocket 
44,45,46
 and a conformational change brought about by a change in pH to more acid near 
the ORs is thought to be the ligand release mechanism when the BmorPBP1-bombykol 
complex reaches the ORs. 
43,44,54,55
 There is some evidence that BmorPBP1 can bind to both 
bombykol and bombykal.
 56
 However, ligands may be utilising very different molecular 
interactions when they bind to an OBP, which may influence the conformational properties of 
the OBP/ligand complex. 
37
 In this study we set out to annotate all possible OBP genes in the 
B. mori genome, examined the tissue expression patterns of six of the genes from three 
subfamilies and studied the binding of recombinant OBPs to the sex pheromone component 
bombykol and its analogues using a new two-phase binding assay and a competitive binding 
assay with a fluorescent probe. As a consequence of this work we also investigated the crystal 
structures of BmorGOBP2 complexed with bombykol and the analogues.  
 
Results  
 
Identification of OBPs in the Bombyx mori genome and EST libraries  
To identify putative OBPs in the B. mori genome (21,302 peptide sequences) and EST 
libraries (245,762 ESTs) we utilised our in house developed MotifSearch algorithm.
 17
 In this 
case we combined the sequences motifs used previously for Classic and Atypical OBPs of D. 
melanogaster and Anopheles gambiae.
 14, 17
 Thus the sequence motifs used in the MotifSearch 
algorithm are C1 X15-39 C2 X3 C3 X21-38 C4 X7-15 C5 X8 C6, and C1 X8-41 C2 X3 C3 
39-47 C4 X17-29 C4a X9 C5 X8 C6 X9-11 C6a for Plus-C OBPs.  The sequences identified 
by the MotifSearch were BLASTp searched against known OBP sequences in the GenBank. 
The sequences with E-value of less than 10
-6
 to any known OBP sequences and with less than 
9 cysteine residues were selected. Other OBP features such as molecular weight, pI and signal 
peptide were also used. The MotifSearch algorithm and BLAST identified 13 putative OBP 
genes. No additional PBPs and GOBPs were found apart from the previously identified 
BmorPBP1, BmorPBP2, BmorPBP3, BmorGOBP1, BmorGOBP2.
20,49 
However, seven 
 6 
BmorABPx homologues (BmorOBP1, BmorOBP2, BmorOBP3, BmorOBP4, BmorOBP5, 
BmorOBP6 and BmorOBP7) were found.  The deduced protein sequences and the alignment 
of these sequences are presented in Figure 1 and the data were used to construct a 
phylogenetic tree (Figure 2) which clusters the sequences into three distinct groups; PBPs, 
GOBPs and ABPs. The seven new OBPs are clustered with ABPx. The total number of 13 
OBPs for B. mori is much less than that found in Anopheles gambiae (66) and D. 
melanogaster (49) 
17
, but is comparable to the numbers found in the honey bee Apis melifera 
57
  and the pea aphid Acyrthosiphon pisum (unpublished). 
 
Expression of Bombyx mori OBPs  
The levels of transcripts of six B. mori OBPs, BmorPBP1, BmorPBP2, BmorPBP3, 
BmorGOBP1, BmorGOBP2 and BmorABPx in adult moth tissues were measured using qRT-
PCR. The measurements were carried out using two internal controls, an elongation factor 
and an actin. Results with the elongation factor are shown in Figure 3 and similar results were 
obtained with actin (data not shown). In general the levels of transcripts were very low in all 
tissues except in antennae where BmorPBP1, BmorGOBP1, BmorGOBP2 and BmorABPx 
were highly expressed. These results are consistent with the high levels of the proteins 
encoded by these genes found in antennae by Western blot analysis and immunocytochemical 
labelling experiments. 
2,21
 Our results also show very low and insignificant transcript levels 
for BmorPBP2 and BmorPBP3 in all tissues in agreement with previous findings using in situ 
hybridisation. 
49
 Thus our data show that at least one member of each phylogenetic cluster of 
B. mori OBPs is expressed at high levels in the antennae and could therefore be involved in 
detection of odour ligands.  
 
Competitive binding of ligands to Bombyx mori OBPs    
Displacement of the fluorescent probe N-Phenyl-1-naphthylamine (NPN) has been used 
previously to assess binding of ligands to insect OBPs 
22,58
 and the fluorescence emission of 
BmorGOBP2 in the presence of NPN is shown in Figure 4. The intrinsic fluorescence of the 
 7 
single tryptophan in BmorGOBP2 shows a strong blue shift (330 nm) compared to tryptophan 
in solution (348 nm) in the absence of NPN, indicating that the tryptophan is buried in the 
core of the protein. The binding of NPN to BmorGOBP2 reduces the intrinsic fluorescence 
emission of the tryptophan at 330 nm and initiates a new emission peak at 395 nm, indicating 
the bound NPN lies close to the tryptophan, as there is resonance energy transfer from the 
tryptophan resulting in the increase in the NPN fluorescence at 395 nm. This is also true for 
the other OBPs (data not shown). The displacement of NPN by ligands leads to a loss of the 
emission at 395 nm. We measured the NPN displacement for five of the B. mori OBPs 
(BmorPBP1, BmorPBP2, BmorGOBP1, BmorGOBP2, BmorABPx) by bombykol and four of 
its analogues bombykal, (10E,12Z)-tetradecadien-1-ol, (8E,10Z)-hexadecadien-1-ol and 
(10E)-hexadecen-12-yn-1-ol (for the synthesis of these compounds see Supplementary Figure 
1). 1-Hexadecanol was also used as a control. The results of the fluorescence displacement 
are shown in Figure 5 and the differences between displacement of NPN by bombykol and 
bombykal for B. mori OBPs are summarised in Figure 6. This shows that it is only for 
BmorGOBP2 that bombykol can displace more NPN from the binding pocket than can 
bombykal. The differential NPN displacement from BmorGOBP2 by bombykol and 
bombykal increased with increased ligand concentration (Figure 5A) with a reduction in NPN 
fluorescence of 59.3±3.1% (n=4) by bombykol and 19.9±0.5% (n=2) by bombykal at the 
highest ligand concentration (7 uM) (Figure 6). For BmorPBP1 there was no difference in 
binding between bombykol and bombykal with the reductions of the NPN fluorescence being 
57.0±2.3% (n=5) and 51.8±2.8% (n=2), respectively, at 7 uM (Figure 6). Both BmorPBP2 
and BmorABPx bound bombykol and its analogues with much less discrimination. The 
change of the functional group from an alcohol in bombykol to an aldehyde in bombykal or 
from double bond in bombykol to a triple bond in (10E)-hexadecen-12-yn-1-ol and the 
removal of double bonds (1-hexadecanol) almost abolished the NPN displacement (Figure 
5A). However, there was no significant difference in the displacement between bombykol and 
(8E,10Z)-hexadecadien-1-ol, and the shorter molecule (10E,12Z)-tetradecadien-1-ol  
decreased the NPN fluorescence to 59.3±2.8% (n=4).  
 8 
  
Non-fluorescent assays of ligand binding to Bombyx mori OBPs.  
We first tested the ability of BmorPBP1 to bind to bombykol and the control ligand 1-
hexadecanol, alone or mixed together, using a cold binding assay.
 40
 There was no difference 
in binding to these two structurally different compounds when they were tested alone but 
when they were mixed there was discrimination between the ligands i.e. more bombykol than 
1-hexadecanol was detected bound to BmorPBP1  (data not shown). Therefore, all subsequent 
binding experiments were carried out using mixtures of ligands. All of the B. mori OBPs 
tested bound to bombykol and its four analogues but the BmorGOBPs and BmorABPx bound 
better than did BmorPBP1 (Figure 7A). There was also no difference between the binding of 
bombykol and bombykal to BmorPBP1, consistent with our competitive binding results and 
those of others. 
56
 
In this cold binding assay, ligands could be released from the binding pocket during 
the washing step when the equilibrium is broken.  We therefore developed a ‘two-phase’ 
binding assay. In this the protein in buffer is incubated with a mixture of ligands dissolved in 
hexane in two phases. Depletion of ligands from the top phase was measured by GC and 
compared with a control. The results for the five B. mori OBPs and five ligands are shown in 
Figure 7B.  Again there is no significant difference in the binding of bombykol and bombykal 
to BmorPBP1, BmorPBP2 or BmorABPx but BmorGOBP2 did bind more to bombykol than 
to bombykal.  
 
X-ray structure of BmorGOBP2.  
The structure of BmorGOBP2 was solved in the presence of bombykol, bombykal, (8E,10Z)-
hexadecadien-1-ol, (10E)-hexadecen-12-yn-1-ol, (10E,12Z)-tetradecadien-1-ol and no added 
ligand (Table 1).  The BmorGOBP2/ligand complexes crystallised in two related crystal 
forms differing in the length of the c axis with bombykol and (10E)-hexadecen-12-yn-1-ol 
structures with a c axis of 189 Å and the other structures  with a c axis of 172Å (Table 1).  
There is a greater root mean square deviation (RMSD) for Cα-atoms of matched residues 
 9 
between the complexes from the different cell dimensions than within a group (e.g. 
bombykol/bombykal=0.52 Å over 139 residues; bombykol/(10E)-hexadecen-12-yn-1-ol 
=0.13 Å over 141 residues).  The differences lie in the regions of amino acids 39-41, 62-66, 
104-106, 123-128 and the C-terminus 139-141 (Figure 8A).  These changes are of a similar 
size to those reported 
37
 as being responsible for the activation of the OBP LUSH of D. 
melanogaster, where the breaking of the salt-bridge between Lys87 and Asp118 either by 
addition of ligand 11-cis-vaccenyl acetate (cVA) or by mutation of Asp118 to Ala118 
conferred activation of pheromone-sensitive neurons in a stimulation assay.  However, 
inspection of all of the loops that differ in the BmorGOBP2 structures shows that they are 
involved in crystal contacts in one or both forms so the conformational changes may not have 
physiological significance.   
The structure of BmorPBP1 with bombykol (PDB ID: 1DQE) 
13
 was the only 
previous OBP structure that gave a marginal solution calculated with PHASER. 
59
 The RMSD 
of Cα-atoms is 1.6 Å over 120 of 137 residues after refinement. The most significant 
differences between BmorGOBP2 and BmorPBP1 are at the C-terminus and in the second 
helix (Figure 9A). In BmorGOBP2 the longer C-terminal tail forms a regular amphipathic 
alpha helix that packs across the top of the N-terminal helix whereas in the BmorPBP1 
complex with bombykol the C-terminus inserts between the first and second helices to close 
off the binding pocket. 
13,43,44,45
 The region equivalent to the second helix of BmorPBP1 is not 
a regular helix and the backbones of the two proteins take a completely different path between 
amino acid residues 29 and 37 including a bulge of residues 33-35 in BmorGOBP2 that 
occupies the position of the C-terminus in the BmorPBP1 structure. Probably the most 
significant residue in the structural change is Phe41 in BmorGOBP2 which is much more 
deeply buried in the protein than is Tyr41 in BmorPBP1 and occupies the space of the last 
turn of the second helix in BmorPBP1 (Figure 9A).  In contrast the side chain of Tyr41 of 
BmorPBP1 interacts with the side chain of Asp32 which reinforces the second helix in 
BmorPBP1.  The equivalent of position 41 is also a phenylalanine in BmorGOBP1 but a 
 10 
tyrosine in all of the PBPs, indicating that this is a major distinction between the two 
subfamilies (Figure 1).    
 
X-ray analysis of ligand binding to BmorGOBP2.  
Inspection of the difference maps of the BmorGOBP2 structures revealed evidence of tubular 
density in their hydrophobic cavities.  In the structure with no added ligand, the C-terminus 
does not occupy the binding site as seen with BmorPBP1, but this was only achieved with 
BmorPBP1 either at low pH or after exhaustive removal of the substrate from the binding site. 
43,44,45,46
.  The quality of the ligand density was generally poorer than that for the protein as a 
whole probably reflecting a degree of conformational flexibility as well as possible partial 
occupancy of the co-crystallised ligands. The Bfactors for the ligands are significantly higher 
than for the protein, reflecting the conformational flexibility of the ligand within the binding 
site.  In the case of the bombykol structure this is 29.0 as opposed to 14.7 for the protein.  The 
ratios of these values are comparable to other OBP structures for example with that of 
BmorPBP1 with bombykol 
13 
(1dqe) where the average ligand B factor is 40.0 compared to 
the protein average of 25.3 or for LUSH with 11 cis-vaccenyl acetate 
37
 (2gte) where the 
ligand B factor is 24.8 compared to a protein B factor of 10.9.  For the other GOBP2 ligand 
complexes in this paper the ligand B factors are higher, probably reflecting partial occupancy 
as well as conformational flexibility as these ligands bind with lower affinity.    
The most striking feature of the BmorGOBP2/ligand complexes is that the conserved 
Ser56 residue does not appear to take part in hydrogen bonding to the ligands in contrast to 
the bombykol bound structure of BmorPBP1. 
13
 Instead, each examined ligand appears to 
make some kind of interaction with Arg110.  In all structures the ligand density although not 
of the highest clarity is clearly directed towards Arg110 and not Ser56 (Figure 9B,C).  This 
residue is conserved as arginine in BmorGOBP1, BmorGOBP2, BmorPBP2 and BmorPBP3 
(and BmorOBPs 4, 5 and 6) but interestingly is a tryptophan in BmorPBP1 (Figure 1). The 
interaction with Arg110 involves hydrogen bonding from the polar head group of the ligands 
to the epsilon amide of the arginine.  However, it is not clear whether this interaction always 
 11 
occurs directly, or is propagated through a water molecule.  There is fairly unambiguous 
density supporting the role for a water molecule in the structures with (10E,12Z)-
tetradecadien-1-ol, (8E,10Z)-hexadecadien-1-ol and (10E)-hexadecen-12-yn-1-ol. However, 
in the bombykol and bombykal bound structures the density is less clear cut and in the case of 
bombykol both conformations have been modelled as equally valid interpretations of the 
density.  The Arg110 residue is present in a mixture of two conformations, to a greater or 
lesser extent depending on the nature of the ligand present.  One conformation presents the 
epsilon amide of Arg110 for hydrogen bonding within the pocket, and is the major 
conformation for the bombykol complex.  In the other conformation the guanidine group of 
Arg110 is flipped inwards occupying more space in the protein interior.  Based on likely 
bonding distances, the second conformation is not involved in hydrogen bonding to water or 
directly to ligand and may represent the unliganded fraction.  This second conformation is 
dominant in the ligand free structure and is more prevalent in the more weakly binding 
ligands than in the bombykol complex indicating that there is probably partial occupancy of 
the ligand site in these cases.  
The extended interaction via a water molecule makes the formation of an additional 
hydrogen bond to Glu98 possible.  This residue has been suggested as being of importance in 
molecular dynamics studies of ligand binding in BmorPBP1. 
55,56
 In this study a hydrogen 
bonding network involving the side chain of Glu98 and the main chain amide of Leu68 is 
implicated in a conformational change allowing ligand release via loss of restraint of the beta 
II turn region of the molecule when ligand competes for hydrogen bonding to Glu98.  The 
beta II turn is a structural feature conserved in BmorGOBP2 as is a hydrogen bond to the 
amide of residue 68 (a methionine in BmorGOBP2). The bombykal polar group is an 
aldehyde and as such it is only able to accept hydrogen bonds. This is in contrast to the 
hydroxyl groups of the other ligands that are able to both accept and donate. This might be a 
significant feature as bombykal would not be able to form the additional hydrogen bond to 
Glu98 unless that residue was protonated.  However, given that the pH of crystallisation is 8.5 
 12 
this may be unlikely. The loss of such a bonding interaction might explain the differences 
observed in binding between bombykal and bombykol.  
 
Discussion  
 
The transcripts of BmorPBP1, BmorGOBP1, BmorGOBP2 and BmorABPx are highly 
expressed in antennae and when recombinant proteins from these genes were studied all but 
BmorGOBP1 bound the sex pheromone bombykol and its analogues. It is possible that 
BmorGOBP1 is an inactive allelic variant as reported in Manduca sexta. 
25
 Both the 
competitive binding assay and non-fluorescent binding measurements showed a broad and 
overlapping ligand spectrum for all of the OBPs and therefore they could transport any of the 
three known pheromone components to the ORs in the chemosensilla. However, there is 
evidence from the binding studies that BmorGOBP2 can discriminate between the sex 
pheromone components bombykol and bombykal. It is possible that the combinatorial actions 
by OBPs and ORs may provide the foundation for insects to discriminate various odorants as 
reported in mammalian species. 
60,61
 
  For the first time we report X-ray structures of BmorGOBP2 complexed with 
bombykol and four of its analogues. Although there are some significant structural differences 
between BmorGOBP2 and BmorPBP1, in particular in the region of the second helix, most of 
the main contributors to the ligand binding pocket are conserved. However, the mode of 
bombykol binding to BmorGOBP2 differs from that found for BmorPBP1.  In BmorGOBP2 
the hydroxyl hydrogen of bombykol forms a hydrogen bond to Arg110 probably via a water 
molecule, whereas in BmorPBP1 its hydrogen binds to Ser56.   Within the B. mori OBPs it is 
BmorPBP1 that is the outlier having a tryptophan in the place of Arg110 found in most other 
OBPs. The GOBPs differ from the PBPs at residue Phe41 where the PBPs have a tyrosine.  It 
is proposed from molecular dynamics studies 
55,56
 and 3D structures of BmorPBP1 
13,43,44,62
 
that there are two modes of bombykol entry and exit from the binding pocket the so called 
front and back exits.  The front exit involves the opening of the flap formed by residues 60-68 
 13 
which is thought to be controlled by the His69, His70 and His95. These residues are 
conserved throughout the GOBPs and PBPs.  We see involvement of Glu98 in binding 
ligands in the resting state in BmorGOBP2. This residue is conserved in all the B. mori 
GOBPs and PBPs except BmorPBP2 where it is a serine. Glu98 in BmorPBP1 is proposed to 
provide an intermediate hydrogen bond on the front binding pathway 
55
 and is hydrogen 
bonded to His95, one of the residues that controls the opening of the flap. This potentially 
allows ligand binding to control the opening of the pocket and is a mechanism of 
communicating ligand binding to the exterior surface of the protein. His95 is in multiple 
conformations in the BmorGOBP2 complexes with bombykal, (10E,12Z)-tetradecadien-1-ol, 
(8E,10Z)-hexadecadien-1-ol and the structure without added ligand but this may be an effect 
of crystal packing. The back exit involves the opening blocked by the C-terminus of the 
BmorPBP1/bombykol structure but not in the structures with the non-natural ligands 2-
isobutyl-3-methoxypyrazine and iodohexadecane. 
62
 In the BmorGOBP2 structure this 
opening is blocked by amino acid residues 33 to 35, which probably means that this second 
mode of entry is not available, as the basis of this conformational difference is hydrophobic 
packing of Phe41 which is unlikely to undergo movements that open this pocket.  It should 
however be noted that closure of the binding pocket is not necessary for ligand binding as 
structures of BmorPBP1 with 2-isobutyl-3-methoxypyrazine and iodohexadecane 
61
 have a 
disordered C-terminus and the pocket remains accessible.    
Recently an alternative model of activation where the OBP-ligand complex interacts 
with the olfactory receptor has been proposed based on conformational differences in the 
crystal structure of the D. melanogaster OBP LUSH with its physiological ligand compared 
to other ligands.  In LUSH conformational changes on the activating ligand (cVA) binding 
lead to the breaking of the salt bridge between Lys87 and Asp118.  Mimicking of this salt 
bridge disruption in the D118A mutant gave a mutated protein that would constitutively 
activate T1 neurons when the receptor Or67d was present without the need for ligand.  The 
conformational shift is thought to be driven by movements of Phe121 in the C-terminus.
 37
   In 
BmorGOBP2 there is a structurally analogous salt bridge to that in LUSH, between Lys89 
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and Glu125. This is extended in the bombykol structure to 3.4 Å compared to 2.9Å in the 
bombykal structure but is certainly not broken. We see other conformational changes of a 
similar magnitude between the BmorGOBP2/bombykol and bombykal structures but cannot 
rule out these being purely due to crystal packing differences.   
In the honey bee PBP ligand binding is dependent on a low pH and protonation of 
Asp35 which locks down the C-terminus in a conformation that closes the active site by a 
hydrogen bond to the main chain of Val118. 
63
 In BmorPBP1/bombykol structure the C-
terminus blocks the rear entry to the pocket with Val135 coming within 4Å of bombykol.  
However, it is not immediately apparent why this interaction is not reiterated in the complex 
with iodohexadecane as there is similar exposure of the aliphatic chain for Val135 to interact 
with. 
44, 62
   Therefore there is a possible theme with LUSH, BmorPBP1 and the bee PBP 
having the C-terminus responding in a different manner to physiological ligands than to non-
specific ligands.  However, with BmorGOBP2 due to the blocking of the rear pocket by the 
bulge formed by amino acid 33-35 the C-terminus cannot sense the ligand directly. 
Our data do not agree with previous suggestions that BmorPBP1 is specific for 
bombykol and that BmorGOBP2 is involved in detection of plant volatiles as predicted by the 
immunochemical localisation. Instead we find that both proteins bind to bombykol and 
bombykal.  Our studies also show that BmorGOBP2 binds differently to bombykol and 
bombykal in both a fluorescent competitive binding assay and non-fluorescent binding 
measurements.  The structural evidence would indicate that lack of hydrogen bonds to Glu98 
may be the source of this discrimination.  This suggests that BmorGOBP2 may also have a 
role in pheromone perception as bombykol is a stronger stimulant than bombykal. 
 
 
Materials and Methods 
 
Identification of Bombyx mori sequences containing OBP Motifs.  
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The whole genome peptide sequences of B. mori were downloaded from the Silkworm 
knowledgebase (http://silkworm.genomics.org.cn/jsp/download.jsp) and the EST sequences 
were retrieved from the NCBI EST database (http://www.ncbi.nlm.nih.gov/dbEST/) and 
searched using the OBP ‘MotifSearch’ program described previously. 14,15,16,17 The OBP 
sequences identified were aligned using Clustal X (8.1) 
64
 with default gap-penalty parameters 
of gap opening 10 and extension 0.2.  The phylogenetic tree was then constructed from the 
multiple alignments using MEGA 4 software. 
65
 The final unrooted consensus tree was 
generated with 1500 bootstrap trials using the neighbour-joining method 
66
 and presented with 
a cut off value of 70. 
 
Quantitative RT-PCR (qRT-PCR).  
B. mori cocoons were kindly provided by Prof. YP Haung (Institute of Plant Physiology and 
Ecology, CAS, China) and adult moths were dissected immediately after hatching into 
antennae, heads, legs, wings and the remaining ‘bodies’. Each tissue was ground in liquid 
nitrogen and total RNA extracted using RNAqueous kit (Ambion) and treated with DNaseI 
(Sigma). Two step real time RT-PCR was carried out with the ETROscript kit according to 
the manufacturer’s protocol (Ambion).  Before qRT-PCR, normal RT-PCRs were done with 
each primer pair using Hotstart Taq DNA polymerase (Qiagen) and the products were run on 
1% agarose gels and stained with ethidium bromide to check that the correct products were 
being amplified. The PCR primers were designed with Primer3 (http://frodo.wi.mit.edu/) and 
were: Actin 5’-CGTTCGTGACATCAAGGAGA-3’ and 5’-
ACAGGTCCTTACGGATGTCG-3’; Elongation factor 5’-
CGATGGAAAGGTGCTCCTAA-3’ and 5’-TGACATCGGCAAGTGTGATT-3’; 
BmorGOBP1 5’-CCCATATGGATGTCTACGTCATGAAAGATG-3’ and 5’-
GGAATTCTCATTTGTCCGCTTCCGATTCCA-3’; BmorGOBP2 5’-
ATCATATGACCGCCGAGGTGATGAGCCACG-3’and 5’-
GGAATTCTCAGTATTTTTCGATAACTGCTT-3’; BmorPBP1 5’-
CAGTGGATGCGTCTCAAGAA-3’ and 5’-GTCTCATCGGCTCCATGTTT-3’; BmorPBP2 
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5’-CCCATATGTCTTCAGAAGCAATGAGACACA-3’ and 5’-
GGAATTCTTATATTTCCGTCATAACTTCTC-3’; BmorPBP3 5’-
CCCATATGTCCCGAGATGTGATGACTAATC-3’ and 5’-
GGAATTCTTAGGACTTCCAAGACACCTCAT-3’; BmorABPx 5’-
CCCATATGGCACACGGTCAACTCCACGACG-3’ and 5’-
GGAATTCCTAAATGAGGAAGTAGTCCGCCT-3’.  
The qRT-PCR reactions (20 ul) for each tissue were performed on an ABI 7500 
(Applied Biosystems, Foster City, CA, USA) using 200 ng cDNA from each tissue and 10 
uM gene specific primers. The reactions were hot-started for 2 min at 95C, followed by 40 
cycles of 95C for 15 sec, 60C for 30 sec and 72C for 15 sec. Two B. mori reference genes, 
actin A4 (Genbank accession no. U49644) and elongation factor 1g (Genbank accession no. 
NM_001043387) were used in each qRT-PCR experiment to check loading, reverse 
transcriptase efficiency and the integrity of the transcripts. For each tissue qRT-PCRs were 
run in 6 replicates for the actin gene and 5 replicates for the elongation factor gene with two 
biological samples.     
 
Quantification of relative tissue expression.   
It was found that the expression levels of the reference genes varied between tissues making it 
impossible to have a common calibrator for comparison of the expression levels across 
different tissues. Therefore the ‘cycle threshold’ scores (Cts) of the reference genes were 
determined in each tissue and the relative expression levels of each gene were calculated 
against the expression levels of the reference gene in the same tissue. Raw Cts were converted 
to quantities representing relative expression levels using a modified comparative Ct method 
67
 with correction for different amplification efficiencies. 
68
 Briefly, after qRT-PCR Ct values 
were exported into the LinRegPCR program to correct the amplification efficiencies for each 
reaction.  The relative expression levels (Pfaffl ratio) of each OBP gene to the reference gene 
were then calculated in each tissue from [(E,obp
ΔCt,obp
]/[(E,ref
ΔCt,ref
], where E,obp and E,ref 
 17 
are the corrected amplification efficiencies for the reference and OBP gene, respectively, and 
ΔCt,obp
 
is calculated from [Ct,obp of antennae-Ct,obp of body] and ΔCt,ref is 
calculated [Ct,ref of antennae-Ct,ref of body].  These ratios were used to compare the 
relative expression levels between genes in a specific tissue. When comparing the expression 
levels of an OBP gene between tissues the expression levels were normalised against those of 
the same gene in the body.  
 
Protein expression and purification of recombinant OBPs.  
Full-length cDNAs encoding mature BmorPBP1, BmorPBP2, BmorGOBP1, BmorGOBP2 
and BmorABPx were cloned into the bacterial expression vector pET17b (Novagen, 
Darmstadt, Germany) between the NdeI and EcoRI restriction sites. All cloned sequences 
were verified by sequencing and plasmids with the correct inserts were transformed into 
BL21(DE3)pLysS E. coli cells and protein synthesis induced at OD600 of 0.5-0.8 with IPTG (4 
mM) for 3 hours. All OBPs were found to be expressed as inclusion bodies and solubilisation 
was performed by denaturation in urea/DTT, renaturation and extensive dialysis, using a 
protocol applied successfully to other OBPs 
58.
 The recombinant proteins were purified by 
two rounds of anion-exchange chromatography using a HiPrep 16/40 column (GE Healthcare) 
filled with DE-52 resin (Whatman), followed by gel filtration on a Suphacryl S-200 HiPrep 
26/60 column (GE Healthcare). A MonoQ column was also used at the final stage of 
purification. The purified proteins were stored at -20
o
C in 20mM Tris-HCl pH 7.4 buffer.  
  
Chemical synthesis.  
The four analogues of bombykol, including bombykal were synthesized in house and the 
synthesis schemes are detailed in Supplementary Figure 1.  NMR and GC analyses were used 
to confirm the structure and purity of the synthesized compounds. 
1
H and 
13
C NMR 
spectroscopy were performed using a Bruker 500 Advance NMR spectrometer with 
1
H 
referenced to CDCl3 (7.25 ppm), 
13
C to CDCl3 (77.0 ppm). Purified compounds were 
 18 
analyzed on a Hewlett-Packard 5880 GC, fitted with a nonpolar HP-1 capillary column (40 m, 
0.32mmID, 0.52-¹mfilm thickness), a cool-on-column injector and a flame ionization detector 
(FID). The GC oven temperature was maintained at 40
o
C for 1 min and then raised by 10
 o
C 
/min to 200
 o
C and the carrier gas was nitrogen.  
 
Fluorescence competitive binding assay.  
To measure the binding of the fluorescent probe NPN to OBPs, a 2 uM protein solution (1 
mL) in 20 mM Tris-HCl, pH 7.4, was titrated with aliquots of 1 mM NPN dissolved in 
methanol to final concentrations of 0.05–22 uM. The protein/NPN complex was excited at 
280 nm and emission spectra recorded between 300 and 450 nm. The competitive binding of 
ligands was measured by using NPN (4 uM) as the fluorescent reporter and 0.05-7 uM 
concentrations of each ligand dissolved in methanol, which gave molar ratios from 0.01 to 
1.61 (bombykol:NPN). The total volume of methanol in the protein solution was maintained 
at 21 ul (2.1%) by adding methanol without ligands. Bound ligand was evaluated from the 
values of fluorescence intensity assuming that the protein was 100% active, with a 
stoichiometry of 1:1 protein:ligand at saturation.  
 
Cold binding assay and two-phase binding assay.  
The cold binding assay was developed and detailed by Leal et al. 
40
 Each experiment was 
performed with at least three replicates and repeated at least twice. The binding of ligands to 
OBPs was quantified using GC on a HP 6890 Series GC system (Hewlett Packard, USA)
 
with 
a wax column (HP-5MS, 25 m x 0.25 mm; 0.25 µm; Agilent Technologies)
 
operated under 
the following temperature program: 100°C for 1
 
min, increased to 250°C at a rate of 10°Cmin
-
1
, and held
 
at the final temperature for 10 min. Each sample was analysed
 
twice. The amount 
of each ligand in the hexane fraction was calculated from the GC traces using a single point 
internal standard. The first analysis contained a known amount of internal standard and the 
compounds of interest and the binding of the ligand was calculated from: 
Equation 1: Internal Response Factor (IRF) = [areaIS x amountSC]/[amountIS x areaSC],  
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Equation 2:  amount of specific compound = [amountIS x areaSC x IRF]/areaIS, 
Where, IS is the internal standard and SC is the specific compound of interest. 
 In the two-phase binding assay 50 ul of 20 mM Tris buffer (pH 7.0 or pH 5.0) 
containing protein (13 uM) was added to the 100-µl V-vial and then 20 ul of hexane 
containing a mixture of ligands (14 uM each) including bombykol was layered on top, which 
gave a molar ratio of 3:1 (protein:ligand) [higher concentrations up to 10 mM of protein were 
used and similar results obtained (data not shown)]. The two phases were then mixed gently, 
centrifuged at 13,000 x g for 10 min and then incubated at room temperature for at least 2 
hours. After incubation 2 ul of the top phase containing the ligands was injected into the GC 
and the amount of ligand which had gone into the protein phase was determined from the GC 
trace using Equations 1 and 2 (above) and comparison with the results obtained before 
incubation and without protein.  
 
Crystallisation and 3D structure of BmorGOBP2.   
BmorGOBP2 was concentrated to 10mg/ml and co-crystalised with a ten fold excess of 
ligand. The GOBP2/bombykol complex was found to crystallise in Hampton screen 1, 
condition 6, (30% Peg 4000, 200mM MgCl2, 100mM Tris pH 8.5) at 16C and other 
complexes crystallised in similar conditions. Diffraction experiments were performed at the 
Diamond Light Source, Harwell, UK.  25% glycerol in the mother liquor was used as a 
cryoprotectant.  The best crystals diffracted to below 2Å resolution Data were integrated in 
MOSFLM 
69
 and input into the molecular replacement workflow MrBump, 
70
 where the space 
group P3221 and search model 1DQE were found to give the best solution using Phaser.
59
 The 
model was refined with Refmac 
71
 and phenix.
72
 Model building was performed with the 
program Coot. 
73
 After several rounds of refinement, the ligand was fitted to the difference 
map density present in the molecular cavity.   Subsequent ligand structures were solved using 
the bombykol structure with the ligand and waters removed as a starting structure using a 
constant set of Rfree reflections. 
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GenBank accession number: X94987 (BmorPBP1), AM403100 (BmorPBP2), AM403101 
(BmorPBP3), X94988 (BmorGOBP1), X94989 (BmorGOBP2), X94990 (BmorABPx), 
FM876234  (BmorOBP1), FM876235 (BmorOBP2),  FM876236 (BmorOBP3),  FM876237 
(BmorOBP4), FM876238  (BmorOBP5),  FM876239 (BmorOBP6),  FM876240   
(BmorOBP7).  
 
RSCB Accession numbers: 2wc5 (bombykol direct to Arg110), 2wc6 (bombykol via water 
to Arg 110), 2wch (bombykal), 2wcj ((10E,12Z)-tetradecadien-1-ol), 2wck (no ligand), 
2wcl ((8E,10Z)-hexadecadien-1-ol)), 2wcm ((10E)-hexadecen-12-yn-1-ol)) 
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Figure legends 
 
Figure 1.  Sequence alignment of OBPs identified in the Bombyx mori genome.  The full-
length OBP sequences were aligned using Clustal X 8.1 
64
 with default gap-penalty 
parameters of gap opening 10 and extension 0.2.  The numbers in parenthesis are the 
percentage identity of each sequence to BmorGOBP2. Residues in black are the highly 
 29 
conserved (more than 80% identical over all sequences) and residues in grey are conserved to 
a secondary level (more than 60% but less than 80% identical over all sequences). 
 
Figure 2. Phylogenetic relationship between Lepidopteran OBPs. The unrooted consensus tree 
was constructed from the multiple alignments using MEGA4 software 
65 
and generated with 
1500 bootstrap trials using the neighbour-joining method 
66
 and presented with a cut off value 
of 65. The numbers are the bootstrap values calculated from 1500 replicates. Bmor, Bombyx 
mori; Lma, Leucophea madderae; Mbra, Mamestra brassicae; Aper, Antheraea pernyi; Apol, 
Antheraea polyphemus; Msex, Manduca sexta; Hvir, Heliothis virescens; Avel, Argyrotaenia 
velutinana; Cros, Ceratitis rosa; Cpar, Choristoneura parallela; Cpin, Choristoneura pinus; 
Cmur, Choristoneura murinana; Epos, Epiphyas postvittana; Pgos, Pectinophora gossypiella; 
Ofur, Ostrinia furnacalis; Onub, Ostrinia nubilalis; Aips, Agrotis ipsilon;  Aseg, Agrotis 
segetum; Hass, Helicoverpa assulta; Harm, Helicoverpa armigera; Hzea, Heliothis zea; Ldis, 
Lymantria dispar; Sexi, Synanthedon exitiosa; Ycag, Yponomeuta cagnagellus; Sfru, 
Spodoptera frugiperda; Pxyl, Plutella xylostella. 
 
Figure 3. OBP transcript levels (relative to the elongation factor) in different parts of adult 
Bombyx mori, measured by quantitive real time RT-PCR (see Materials and Methods).  
 
Figure 4. Fluorescence emission spectra of BmorGOBP2. The protein (2 uM) was excited at 
280 nm and fluorescence emission spectra recorded between 310 and 455 nm. A. the emission 
spectra with different concentrations from 0 uM (light blue line) up to 16 uM (dark blue line) 
of NPN. B. The plot of peak emission at 330 nm and 395 nm against NPN concentrations.  
 
Figure 5. Fluorescence displacement of NPN from Bombyx. mori OBPs by bombykol (♦)and 
its analogues bombykal (■), (10E,12Z)-tetradecadien-1-ol (X), (10E)-hexadecen-12-yn-1-ol 
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(*), (8E,10Z)-hexadecadien-1-ol (▲) and hexandecanol (●). A. BmorGOBP2, B. 
BmorGOBP1, C. BmorPBP2, D. BmorPBP1, E. BmorABPx. The protein and NPN were both 
at 2 uM. The protein/NPN complexes were excited at 280 nm and the fluorescence emission 
at 395 nm was measured before and upon titration with methanol solutions of the competitors 
to final concentrations of 0.5-7 uM. The reductions in NPN fluorescence emission at 395 
were normalised to the NPN fluorescence before titration. The decrease in NPN fluorescence 
intensity at the emission maximum (395-400 nm) at increasing concentrations of competitors 
is presented as (Fligand/Fnpn) with Fligand=the peak fluorescence intensity at a distinct 
competitor concentration. Fnpn=the peak fluorescence intensity of the OBP/NPN complex.  
 
Figure 6. Displacement of the fluorescent probe NPN by bombykol and bombykal. The 
protein and NPN were both incubated at a concentration of 2 uM. The OBP/NPN complexes 
were excited at 280 nm and the fluorescence emission at 395 nm was measured before and 
upon titration with bombykol (white bar) or bombykal (black bar) at a final concentration of 7 
uM. The reductions in NPN fluorescence emission at 395 nm were normalised to the NPN 
fluorescence before titration. Each column is the average of three replicates and the bar 
denotes the standard error. 
 
Figure 7. Binding of bombykol and its analogues  to Bombyx. mori OBPs as measured by A. 
the cold binding assay and B. the two-phase binding assay (see Materials and Methods). Each 
column is the average of three replicates and the bar denotes the standard error.   
 
Figure 8. 3D structures of BmorGOBPs with ligands.  A. Stereo view of the BmorGOBP2 
liganded and apo structures. Bombykol (blue), bombykal (coral), (10E,12Z)-tetradecadien-1-
ol (yellow), (10E)-hexadecen-12-yn-1-ol (cyan), (8E,10Z)-hexadecadien-1-ol (megenta), apo 
(black).  The bombykol ligand is shown in sphere representation. N and C termini and 
periodic residues are as indicated in the right hand image. B.  Stereo view of bombykol plus 
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water structure of BmorGOPB2 with the final 2Fobs-Fcal map in pink contoured at 1.0 
clipped to the ligand and water and the Fobs-Fcal map before modelling the ligand contoured 
at 2.3 unclipped in green.  Side chains of GOBP2 are shown in green.  Ser56 and the 
bombykol of the SSM superposed structure of BmorPBP1 (1dqe) are shown in blue.  C. Fobs-
Fcal electron density maps (represented as blue chickenwire) for the BmorGOBP2 ligands 
before the ligands were added to the structure contoured at 2.3. i) bombykol coordinated 
directly to Arg110 and to the main chain carbonyl of Val66. ii) bombykol coordinated via a 
water. iii) bombykal, coordinated to a water which is also coordinated to Glu98. iv) (8E,10Z)-
hexadecadien-1-ol, coordinated both to Glu98 and water. v) (10E)-hexadecen-12-yn-1-ol, 
coordinated to water and Glu98. vi) (10E,12Z)-tetradecadien-1-ol, coordinated to Glu98 and 
water. Hydrogen bonds are indicated by dashed black lines as predicted by the algorithm of 
the CCP4MG molecular graphics program. 
 
Figure 9. Superposition of BmorPBP1 (pdb code:1DQE) and BmorGOBP2 to show structural 
differences. A. Stereo pair of BmorPBP1 (red), BmorGOBP2 (blue with regions of greatest 
difference in light blue). The disulfide bonds  are yellow. The bombykol ligand is represented 
as cylinders and coloured light blue for the BmorGOBP2 bound conformation and pink for 
the BmorPBP1 bound conformation. The ligand hydrogen bonding residues Ser56 for 
BmorPBP1 and Arg110 for BmorGOBP2 are shown as green cylinders. B. i) Enlarged and 
simplified view of the major structural difference in the rear entry region (C-termini from 
residue 126 and residues 25-49). Features are coloured as described above. A potentially 
important stabilising hydrogen bonding network has been included for BmorPBP1 (Tyr41 and 
Glu32, shown as pink cylinders).  The equivalent Phe41 in BmorGOBP2 (shown as blue 
cylinders) is more deeply buried and occupies the space of the helix in BmorPBP1.  The 
equivalent region of BmorGOBP2 bulges out to occupy the space filled by the C-terminus of 
BmorPBP1.  ii) Cut away view of the ligand binding pocket showing the key hydrogen bonds 
formed with the bombykol hydroxyl.  PBP1 in red/pink and GOBP2 in blue.  Hydrogen 
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bonding side chains in green. C. Schematic representation of the possible hydrogen bonding 
modes of bombykol and bombykal, hydrogen bonds shown as dotted lines.  i) The hydroxyl 
of bombykol able to form two hydrogen bonds to water and Glu98 and ii) the aldehyde of 
bombykal only able to form a single hydrogen bond to water.  
 
 
Supplementary Figure 1. Synthesis of bombykol and its analogues. The name of each 
analogues is given under its structure. The roman numbers in parenthesis and bold indicate 
steps for (I) Synthesis of (10E)-hexadecen-12-yn-1-ol and (10E,12Z)-hexadecadien-1-ol 
(bombykol) (Miyaura et al., 1983): Sonogashira coupling between 1-pentyne and (E)-11-
iodoundec-10-en-1-ol, using PdCl2(PhCN)2 gave  which was subsequently reduced to 
(10E,12Z)-hexadecadien-1-ol in the presence of a Zn/Cu/Ag reagent (Mcelfresh et al., 1999). 
(II) Synthesis of (10E,12Z)-hexadecadienal (bombykal): Oxidation of bombykol using TPAP 
and NMO gave bombykal. (III) Synthesis of (10E,12Z)-tetradecadien-1-ol: Sonogashira 
coupling between 1-propyne and (E)-11-iodoundec-10-en-1-ol using PdCl2(PhCN)2 gave an 
enyne which was subsequently reduced to (10E,12Z)-tetradecadien-1-ol in the presence of a 
Zn/Cu/Ag reagent to give (10E,12Z)-tetradecadien-1-ol. (IV) Synthesis of (10E)-hexadecen-
12-yn-1-ol  and (8E,10Z)-hexadecadien-1-ol: (E)-9-iodonon-8-en-1-ol was obtained by the 
successive treatment of 8-nonyn-1-ol with Schwartz’s reagent (Cp2Zr(H)Cl) and iodine (Ando
 
et al., 1982). Sonogashira coupling between 1-heptyne and (E)-9-iodonon-8-en-1-ol using 
PdCl2(PhCN)2 gave (10E)-hexadecen-12-yn-1-ol which was subsequently reduced to 
(8E,10Z)-hexadecadien-1-ol in the presence of a Zn/Cu/Ag reagent.  
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Table 1. (continue) Data Collection and Refinement Parameters for BmorGOBP2/ligand and apo-BmorGOBP2 structures.    
* First two columns refer to different models of the same data set. 
Parameter 
Bombykol direct to 
Arg110 * 
Bombykol via 
water * 
Bombykal 
(10E,12Z)-
tetradecadien-1-ol 
No ligand 
(8E,10Z)-
hexadecadien-1-ol 
(10E)-hexadecen-
12-yn-1-ol 
Resolution (Å) 31.6-1.9 (2.0-1.9) 31.6-1.9 (2.0-1.9) 43.1-1.7(1.79-1.7) 57.5-1.4(1.48-1.4) 42.9-1.6 (1.69-1.60) 43.0-1.6 (1.69-1.6) 63.2-1.5 (1.54-1.5) 
Completeness (%) 99.2(100) 99.2(100) 98.1(94.7) 94.7(89.6) 84.7(78.6) 85.1(85.5) 92.9(95.4) 
Rmerge (%) 0.097(0.23) 0.097(0.23) 0.098(0.22) 0.07(0.25) 0.11(0.30) 0.07(0.32) 0.11(0.38) 
I/б 11.1(6.5) 11.1(6.5) 10.3(4.9) 13.3 (4.8) 12.5(5.9) 12.0(4.5) 14.8(3.8) 
Total reflections 47846(7416) 47846(7416) 60818(6337) 126,061(12783) 91,561(13,436) 57,992(9,384) 121787(18940) 
Unique reflections 9583(1903) 9583(1903) 11977(1735) 19390(2591) 13,112(1,726) 13,176(1881) 17328(2487) 
Space group P3221 P3221 P3221 P3221 P3221 P3221 P3221 
Multiplicity 4.7(5.1) 4.7(5.1) 4.8(3.8) 6.0(4.6) 7.0(7.8) 4.4(5.0) 6.4(6.8) 
Cell dimensions        
a (α)  (Å (0)) 33.16 (90) 33.16 (90) 33.08 (90) 33.07  (90) 33.06 (90) 33.03 (90) 33.21 (90) 
b (ß) (Å (0)) 33.16 (90) 33.16 (90) 33.08 (90) 33.07 (90) 33.06 (90) 33.03 (90) 33.21 (90) 
c (γ) (Å (0)) 189.67 (120) 189.67 (120) 172.38 (120) 172.29 (120) 171.63 (120) 172.10 (120) 189.38 (120) 
Beam line DLS I04 DLS I04 DLS MI03 DLS I04 DLS I03 DLS I03 DLS I03 
Resolution (Å) 31.6-1.9 (1.95-1.9) 31.6-1.9 (1.95-1.9) 28.7-1.7 (1.74-1.7) 57.5-1.4 (1.44-1.4) 42.9-1.6(1.65-1.60) 43.0-1.6(1.65-1.6) 28-1.5(1.54-1.5) 
R (outer shell) 16.9(19.4) 17.1 (19.5) 18.2(23.4) 17.8(22.7) 19.5(198) 17.6(20.4) 19.7(24.7) 
Rfree (outer shell) 23.5 (27.0) 23.1 (27.2) 25.4(32.4) 22.8(27.2) 27.4 (26.7) 23.1(24.2) 24.0(30.7) 
Number of atoms        
Protein 1141 1141 1186 1209 1161 1189 1154 
Ligand 17 17 17 15  17 17 
Water 120 121 121 135 80 65 115 
Magnesium 1 1 4 6 3 3 2 
Wilson B Factor 14.1 14.1 16.7 12.0 16.2 17.4 14.7 
Average B-factor (Å2)        
Protein 14.7 14.7 14.8 12.8 14.5 17.1 15.4 
Ligand 27.5 29.0 36.9 29.8  33.8 31.0 
RMSD        
Bond angle (°) 1.8 1.8 1.9 2.0 1.9 1.8 2.0 
Bond length (Å) 0.022 0.022 0.022 0.021 0.022 0.022 0.023 
Ramachandran plot        
Most favoured (%) 99.3 99.3 99.2 99.2 99.2 99.2 98.5 
Allowed (%) 100 100 100 100 100 100 100 
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Figure 3.   
 
 
0
5
10
15
20
25
30
35
BmorPBP1 BmorPBP2 BmorPBP3 BmorGOBP1 BmorGOBP2 BmorABPx
fo
ld
 c
h
a
n
g
e 
re
la
ti
v
e 
to
 e
lo
n
g
a
ti
o
n
 f
a
ct
o
r
Head Leg Wing Body Antennae
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 37 
 
Figure 4.    
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Figure 5.  
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Figure 5.  (cont.) 
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Figure 5.  (cont.) 
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Figure 6.  
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Figure 7.     
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Figure 8.  
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Figure 9 
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Supplementary Figure 1 
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